Joseph Hagan
Vorstandsvorsitzender bei REGULUS THERAPEUTICS INC.
Vermögen: 187 894 $ am 30.04.2024
Profil
Mr. Joseph P.
Hagan is a Chief Executive Officer & Director at Regulus Therapeutics, Inc. He is on the Board of Directors at Regulus Therapeutics, Inc. Mr. Hagan was previously employed as an Independent Director by Aurinia Pharmaceuticals, Inc., an Independent Director by Zosano Pharma Corp., a Chief Financial & Business Officer, Executive VP by Orexigen Therapeutics, Inc., a Partner by GroundSwell Advisors LLC, a Managing Director by Amgen Ventures LLC, a Head-Corporate Development by Amgen, Inc., and an Acting Chief Executive Officer by Unity Pharma.
He also served on the board at accelerator corp, Avidia, Inc., ISB Accelerator Corp., Ren Pharmaceuticals, Inc. and Seredigm Corp.
He received his undergraduate degree from the University of California San Diego and an MBA from Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2024 | 57 112 ( 0,09% ) | 129 644 $ | 30.04.2024 | |
| 23.05.2023 | 11 961 ( 0,01% ) | 58 250 $ | 30.04.2024 |
Aktive Positionen von Joseph Hagan
| Unternehmen | Position | Beginn |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Vorstandsvorsitzender | 04.05.2017 |
Ehemalige bekannte Positionen von Joseph Hagan
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 29.06.2023 |
| ZOSANO PHARMA CORPORATION | Direktor/Vorstandsmitglied | 10.05.2022 |
| OREXIGEN THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.12.2015 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Direktor/Vorstandsmitglied | 30.10.2009 |
| GroundSwell Advisors LLC | Gründer | 01.05.2009 |
Ausbildung von Joseph Hagan
| Northeastern University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Finance |
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | Health Technology |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Commercial Services |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
| GroundSwell Advisors LLC | |
| Unity Pharma | |
Seredigm Corp.
 Seredigm Corp. Pharmaceuticals: GenericHealth Technology Seredigm Corp. develops and supplies drugs that protect against tissue damage in acute and chronic medical conditions. The company was founded by John M. Harlan and Robert K. Winn in 2006 and is headquartered in Seattle, WA | Health Technology |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
